Literature DB >> 22826072

Influence of rapid influenza test on clinical management of children younger than five with febrile respiratory tract infections.

Aneta Nitsch-Osuch1, Ilona Stefanska, Ernest Kuchar, Lidia B Brydak, Iwona Pirogowicz, Katarzyna Zycinska, Kazimierz Wardyn.   

Abstract

Children are an important vector for spreading influenza and they are at increased risk for complications. The appropriate diagnosis of influenza may help start early antiviral treatment and may optimize the use of antibiotics and additional laboratory tests. The objective of this study was to describe the influence of rapid influenza detection test (RIDT) on clinical management of children with acute febrile respiratory tract infections. The method consisted of a prospective, open, cohort study conducted in three primary care clinics in Warsaw, Poland, during the epidemic influenza seasons of 2009/2010 and 2010/2011. A total number of 256 children of the age 0-5 years with symptoms of febrile respiratory tract infection were enrolled into the study. A 115 of them were tested with RIDT (BD Directigen EZ FluA + B) and another 141 children, who were not tested, constituted a control group. We found that RIDT gave positive results in 35 (30%) out of the 115 tested children. Antibiotics, additional blood tests and urinalysis were administered more often in the control group compared with the rapid test group (16% vs. 7%; 14% vs. 5%, and 47% vs. 32%, respectively). Chest radiograms were made only in six cases of children from the control group. We conclude that in children with symptoms of acute febrile respiratory tract infection, the rapid influenza detection test provides a rational use of antivirals, reduces an inappropriate use of antibiotics, and decreases a number of additional tests conducted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22826072     DOI: 10.1007/978-94-007-4546-9_30

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Impact of Rapid Molecular Diagnostic Testing of Respiratory Viruses on Outcomes of Adults Hospitalized with Respiratory Illness: a Multicenter Quasi-experimental Study.

Authors:  Nasir Wabe; Ling Li; Robert Lindeman; Ruth Yimsung; Maria R Dahm; Susan McLennan; Kate Clezy; Johanna I Westbrook; Andrew Georgiou
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

2.  The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients.

Authors:  Nasir Wabe; Ling Li; Robert Lindeman; Ruth Yimsung; Maria R Dahm; Kate Clezy; Susan McLennan; Johanna Westbrook; Andrew Georgiou
Journal:  Med J Aust       Date:  2019-03-05       Impact factor: 7.738

3.  Clinical performance of the Sofia™ Influenza A+B FIA in adult patients with influenza-like illness.

Authors:  Ji Yun Noh; Won Suk Choi; Jacob Lee; Hye Lim Kim; Joon Young Song; Hee Jin Cheong; Woo Joo Kim
Journal:  Diagn Microbiol Infect Dis       Date:  2015-06-10       Impact factor: 2.803

Review 4.  Influenza diagnosis and vaccination in Poland.

Authors:  L B Brydak; A Wozniak-Kosek; A Nitsch-Osuch
Journal:  Respir Physiol Neurobiol       Date:  2013-02-16       Impact factor: 1.931

5.  The Clinical Utility of Point-of-Care Tests for Influenza in Ambulatory Care: A Systematic Review and Meta-analysis.

Authors:  Joseph Jonathan Lee; Jan Y Verbakel; Clare Rosemary Goyder; Thanusha Ananthakumar; Pui San Tan; Phillip James Turner; Gail Hayward; Ann Van den Bruel
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

Review 6.  Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection.

Authors:  Ece Egilmezer; Gregory J Walker; Padmavathy Bakthavathsalam; Joshua R Peterson; J Justin Gooding; William Rawlinson; Sacha Stelzer-Braid
Journal:  Rev Med Virol       Date:  2018-08-13       Impact factor: 6.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.